Annual CFF
$4.13 M
-$4.99 M-54.72%
31 December 2023
Summary:
Adial Pharmaceuticals annual cash flow from financing activities is currently $4.13 million, with the most recent change of -$4.99 million (-54.72%) on 31 December 2023. During the last 3 years, it has fallen by -$1.48 million (-26.31%). ADIL annual CFF is now -69.72% below its all-time high of $13.64 million, reached on 31 December 2021.ADIL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$3.61 M
+$3.20 M+778.23%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly cash flow from financing activities is currently $3.61 million, with the most recent change of +$3.20 million (+778.23%) on 30 September 2024. Over the past year, it has increased by +$3.47 million (+2503.03%). ADIL quarterly CFF is now -60.95% below its all-time high of $9.25 million, reached on 31 March 2019.ADIL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$11.23 M
+$3.47 M+44.75%
30 September 2024
Summary:
Adial Pharmaceuticals TTM cash flow from financing activities is currently $11.23 million, with the most recent change of +$3.47 million (+44.75%) on 30 September 2024. Over the past year, it has increased by +$10.48 million (+1400.48%). ADIL TTM CFF is now -39.91% below its all-time high of $18.69 million, reached on 31 March 2022.ADIL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.7% | +2503.0% | +1400.5% |
| 3 y3 years | -26.3% | -34.4% | -9.4% |
| 5 y5 years | -34.9% | +10000.0% | +19.4% |
ADIL Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -69.7% | at low | -60.4% | -39.9% | +1741.8% | |
| 5 y | 5 years | -69.7% | at low | -60.4% | -39.9% | >+9999.0% | |
| alltime | all time | -69.7% | -61.0% | -39.9% |
Adial Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.61 M(+778.2%) | $11.23 M(+44.8%) |
| June 2024 | - | $411.10 K(-89.3%) | $7.76 M(+5.6%) |
| Mar 2024 | - | $3.82 M(+13.0%) | $7.35 M(+77.8%) |
| Dec 2023 | $4.13 M(-54.7%) | $3.38 M(+2339.7%) | $4.13 M(+452.1%) |
| Sept 2023 | - | $138.70 K(>+9900.0%) | $748.40 K(+22.7%) |
| June 2023 | - | $100.00(-100.0%) | $609.70 K(-0.3%) |
| Mar 2023 | - | $609.60 K(>+9900.0%) | $611.50 K(-93.3%) |
| Dec 2022 | $9.13 M(-33.1%) | $0.00(0.0%) | $9.13 M(-12.1%) |
| Sept 2022 | - | $0.00(-100.0%) | $10.38 M(-34.6%) |
| June 2022 | - | $1900.00(-100.0%) | $15.88 M(-15.0%) |
| Mar 2022 | - | $9.12 M(+627.0%) | $18.69 M(+37.0%) |
| Dec 2021 | $13.64 M(+143.3%) | $1.25 M(-77.2%) | $13.64 M(+10.1%) |
| Sept 2021 | - | $5.50 M(+95.8%) | $12.39 M(+58.0%) |
| June 2021 | - | $2.81 M(-31.2%) | $7.84 M(-19.1%) |
| Mar 2021 | - | $4.08 M(>+9900.0%) | $9.69 M(+72.8%) |
| Dec 2020 | $5.61 M | $0.00(-100.0%) | $5.61 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $950.00 K(-79.6%) | $5.61 M(+20.4%) |
| June 2020 | - | $4.66 M(>+9900.0%) | $4.66 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) | $300.00(-100.0%) |
| Dec 2019 | $9.25 M(+45.6%) | $100.00(-50.0%) | $9.25 M(-1.7%) |
| Sept 2019 | - | $200.00(>+9900.0%) | $9.40 M(-37.6%) |
| June 2019 | - | $0.00(-100.0%) | $15.06 M(-1.9%) |
| Mar 2019 | - | $9.25 M(+5815.7%) | $15.35 M(+141.7%) |
| Dec 2018 | $6.35 M(+1528.0%) | $156.30 K(-97.2%) | $6.35 M(+0.9%) |
| Sept 2018 | - | $5.66 M(+1885.2%) | $6.29 M(+832.3%) |
| June 2018 | - | $285.00 K(+14.0%) | $675.00 K(+5.5%) |
| Mar 2018 | - | $250.00 K(+150.0%) | $640.00 K(+64.1%) |
| Dec 2017 | $390.00 K(+95.0%) | $100.00 K(+150.0%) | $390.00 K(+34.5%) |
| Sept 2017 | - | $40.00 K(-84.0%) | $290.00 K(+16.0%) |
| June 2017 | - | $250.00 K(>+9900.0%) | $250.00 K(>+9900.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | $200.00 K(>+9900.0%) | - | - |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Adial Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual CFF year-on-year change?
- What is Adial Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly CFF year-on-year change?
- What is Adial Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM CFF year-on-year change?
What is Adial Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ADIL is $4.13 M
What is the all time high annual CFF for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual cash flow from financing activities is $13.64 M
What is Adial Pharmaceuticals annual CFF year-on-year change?
Over the past year, ADIL annual cash flow from financing activities has changed by -$4.99 M (-54.72%)
What is Adial Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ADIL is $3.61 M
What is the all time high quarterly CFF for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly cash flow from financing activities is $9.25 M
What is Adial Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ADIL quarterly cash flow from financing activities has changed by +$3.47 M (+2503.03%)
What is Adial Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ADIL is $11.23 M
What is the all time high TTM CFF for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM cash flow from financing activities is $18.69 M
What is Adial Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ADIL TTM cash flow from financing activities has changed by +$10.48 M (+1400.48%)